Other
Thoracotomy
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Thoracotomy is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed6 · 46%
Unknown status3 · 23%
Withdrawn1 · 8%
Not yet recruiting1 · 8%
Terminated1 · 8%
Active, not recruiting1 · 8%
Clinical Trials
Trial Activity
13 trials
Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy
Completed·—·N/A·NCT06685445·60 enrolled
Post- Thoracotomy Paravertebral Block
Completed·—·Phase 2·NCT02886429·60 enrolled
Duloxetine vs Pregabalin for Thoracotomy Pain
Unknown status·—·Phase 4·NCT04782310·75 enrolled
Comparing Efficacy of Different Drugs Combinations for Serratus Anterior Block for Thoracotomy
Unknown status·—·Phase 4·NCT05565235·78 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)